Medical Oncology Clinical Trial
Official title:
Effect on Professional Practice and Health Care Outcomes of Computerized Evidence-based Information System and Clinical Decision Support: A Randomized Controlled Trial in Orthopaedics (GR-2009-1606736)
Implementing an evidence-based computerized decision support system linked to electronic
health records to improve care for cancer patients.
The ONCO-CODES (Computerized DEcision Support in ONCOlogy) trial is a pragmatic, parallel
group, randomized controlled study with 1:1 allocation ratio Study Duration 12 month Study
Center(s) Single-center
Objectives:
The primary outcome of this trial is a process outcome. i.e. the rate at which the issues
reported by the reminders are resolved (resolution rates).
Implementing an evidence-based computerized decision support system linked to electronic
health records to improve care for cancer patients.
Short Title/Acronym ONCO-CODES Protocol Code IRST100.23
Rationale:
Computerized decision support systems (CDSSs) are computer programs that provide clinicians,
staff, patients, or other individuals with person-specific, actionable recommendations or
management options that are intelligently filtered or presented at appropriate times to
enhance health and health care. CDSSs might be integrated with patient electronic health
records (EHRs) and evidence-based knowledge. The Investigators designed a pragmatic
randomized controlled trial to evaluate the effectiveness of patient-specific, point-of-care
reminders generated by the Medilogy Decision Support System (MediDSS) on clinical practice
and the quality of care in the Istituto Scientifico Romagnolo per lo Studio e la Cura dei
Tumori (IRST) IRCCS. The Investigators hypothesize that MediDSS reminders can increase
clinician adherence to guidelines and, eventually, improve the quality of care offered to
hospitalized patient. The adoption of CDSSs is likely to increase across healthcare systems
due to growing concerns about the quality of medical care and discrepancy between real and
ideal practice, continuous calls for a meaningful use of health information technology, and
the increasing use of and familiarity with advanced technology among new generations of
physicians.
Study Design:
The ONCO-CODES (Computerized DEcision Support in ONCOlogy) trial is a pragmatic, parallel
group, randomized controlled study with 1:1 allocation ratio Study Duration 12 month Study
Center(s) Single-center
Objectives:
The primary outcome of this trial is a process outcome. i.e. the rate at which the issues
reported by the reminders are resolved (resolution rates).
Number of Subjects:
The investigators calculated the sample size on the basis of the primary outcome. A sample
of 1,704 reminders will be necessary to detect the difference between the two groups (power
= 0.90; α =0.05, two-sided; 1:1 allocation). Since estimates for intracluster correlation
are not available, Implementing an evidence-based computerized decision support system
linked to electronic health records to improve care for cancer patients.
Diagnosis and Main Inclusion Criteria:
The investigators will include all the patients admitted to the facilities of the IRST
IRCCS. There are no exclusion criteria
Statistical Methodology:
All analyses will follow the intention-to-treat principle: patients will be analyzed in the
group to which they have been randomized. Descriptive statistics will be presented.
All statistical tests will be two-sided. The investigators will use the Stata software to
perform all statistical analyses (Stata Corp., College Station, TX, USA).The investigators
increased the required sample size (by 20%) to 2,046 reminders to account for clustering by
patient.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02824042 -
Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
|
Phase 1 | |
Completed |
NCT02253420 -
COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients
|
Phase 1 | |
Completed |
NCT02357953 -
Transpulmonary Thermodilution Using an Implented Central Venous Access Port
|
N/A | |
Recruiting |
NCT04931329 -
Onco-haematology Vigilance Card
|
||
Terminated |
NCT02138812 -
Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
|
Phase 1 | |
Recruiting |
NCT05356182 -
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
|
N/A | |
Terminated |
NCT02368951 -
Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
|
Phase 1 | |
Not yet recruiting |
NCT05423808 -
Geriatric and Oncological Evaluation With Technology for Holistic Healthcare Management for Older Multimorbid Patients.
|
N/A | |
Terminated |
NCT02439346 -
Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel
|
Phase 1 | |
Recruiting |
NCT05385718 -
Ezra Faster Scan Study
|
||
Completed |
NCT02457351 -
Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study
|
Phase 1 | |
Completed |
NCT02906423 -
Results From a Health System-wide Implementation of a Quality of Life Questionnaire
|
N/A | |
Completed |
NCT01409135 -
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
|
Phase 1 | |
Not yet recruiting |
NCT02327806 -
The Effect of Pullsed Magnetic Field Induction on Improving the Forearm Tissue Muscle Performance
|
N/A | |
Completed |
NCT02639091 -
Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
|
Phase 1 | |
Completed |
NCT02366949 -
Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
|
Phase 1 | |
Not yet recruiting |
NCT06097533 -
Improvement of Quality of Life by Cannabinoids in Oncologic Patients
|
Phase 2/Phase 3 | |
Completed |
NCT02427490 -
A Problem-Solving Intervention for Family Caregivers in Palliative Oncology
|
N/A | |
Recruiting |
NCT05359848 -
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
|
N/A |